Huntsman Cancer Institute

Articles

New Angio-CT Technology Integrates Cutting-Edge Imaging to Enhance Patient Care

November 18th 2025

The new angiography-CT suite at Huntsman Cancer Institute is a regional first, expanding advanced interventional radiology capabilities in the Mountain West.

Study Links Obesity-Driven Fatty Acids To Breast Cancer, Warns Against High-Fat Diets Like Keto

October 22nd 2025

A study suggests that breast cancer patients with obesity could benefit from lipid lowering therapies and should avoid high-fat weight loss regimens.

Ulrich Named President-Elect of AACI

October 10th 2025

Neli Ulrich, PhD, MS, has been elected by the members of the Association of American Cancer Institutes to serve as vice president/president-elect of the AACI Board of Directors.

Huntsman Cancer Institute Earns Several Accolades for Quality of Cancer Care Programs and Facilities

September 12th 2025

Huntsman Cancer Institute has been listed 10th among the top 75 cancer care hospitals in the US.

Leaders Drive Theranostics Expansion to Transform Cancer Care

August 20th 2025

Huntsman Cancer Institute has announced leadership team appointments overseeing clinical and research efforts in theranostics.

Proton Therapy Center Expansion Will Significantly Boost Patient Capacity Across the Mountain West

August 14th 2025

Huntsman Cancer Institute is expanding its proton therapy center, enhancing access to advanced cancer treatment for patients in the Mountain West region.

$31 Million Pledged to Establish the Sigma Chi Center for Advanced Therapeutics and Innovation

July 28th 2025

Huntsman Cancer Foundation and Sigma Chi International Fraternity announced a $31 million pledge for the Sigma Chi Center for Advanced Therapeutics.

Beckerle Steps Down After 20 Years of Distinguished Service as CEO

July 24th 2025

The CEO of Huntsman Cancer Institute is stepping down after holding the role since 2006.

Interdisciplinary Grants Awarded for Cancer-Focused Engineering Projects

July 21st 2025

Innovative engineering teams at Huntsman Cancer Institute tackle cancer treatment challenges through collaborative grants.

Alana Welm, PhD, Named Chair of Oncological Sciences in the Spencer Fox Eccles School of Medicine at the University of Utah

May 23rd 2025

Alana Welm, PhD, is now the chair of the Department of Oncological Sciences in the Spencer Fox Eccles School of Medicine at the University of Utah.

First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial

May 15th 2025

Huntsman Cancer Institute pioneers a clinical trial using deceased donor stem cells, expanding transplant options for patients with aggressive blood cancers.

Researcher Bruce Edgar Elected to National Academy of Sciences

May 8th 2025

Bruce Edgar, PhD, researcher at Huntsman Cancer Institute, has been elected as a member to the National Academy of Sciences.

New Drug Therapy Combination Shows Promise For Advanced Melanoma Patients

March 28th 2025

A federally funded research team is testing a new combination drug therapy that could both treat and prevent melanoma metastasis to the brain.

Anna Parks Receives American Society of Hematology Junior Faculty Scholar Award

February 24th 2025

Anna Parks, MD, Huntsman Cancer Institute investigator, has been awarded the ASH Junior Faculty Scholar Award.

Short-Course Radiation Therapy Effective for Endometrial Cancer Patients

February 12th 2025

Short-course, higher dose vaginal brachytherapy for endometrial cancer had similar effectiveness to more frequent, lower dose sessions.

Dr Schlechter Named Cancer Moonshot Scholar

November 27th 2024

Chelsey Schlechter, MPH, PhD, Huntsman Cancer Institute investigator and assistant professor in the Department of Population Health Sciences at the University of Utah, has been selected as a 2024 Cancer Moonshot Scholar.

Novel Prostate Cancer Treatment Increases Overall Survival Rates for Late-Stage Prostate Cancer Patients

October 31st 2024

Results of the TALAPRO-2 trial showed that a novel prostate cancer therapy has a higher overall survival rate compared to the standard of care drug alone.

Researchers Develop Mechanism that Predicts Severity of Aggressive Form of Breast Cancer

September 13th 2024

Scientists at Huntsman Cancer Institute at the University of Utah, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer.

Landmark Study Shows Elevated Cancer Risk For Women With Endometriosis

July 23rd 2024

Women with severe endometriosis are 10 times more likely to get ovarian cancer, compared to women who do not have the disease.

Researchers Honored for Outstanding Contributions to Cancer Care

June 21st 2024

Three Huntsman Cancer Institute researchers have recently been recognized for their work as outstanding faculty members at the University of Utah.